Factors associated with onset-age in major affective disorders.


Journal

Acta psychiatrica Scandinavica
ISSN: 1600-0447
Titre abrégé: Acta Psychiatr Scand
Pays: United States
ID NLM: 0370364

Informations de publication

Date de publication:
11 2022
Historique:
revised: 25 08 2022
received: 02 06 2022
accepted: 28 08 2022
pubmed: 6 9 2022
medline: 19 10 2022
entrez: 5 9 2022
Statut: ppublish

Résumé

Research findings on factors associated with onset-age (OA) with bipolar (BD) and major depressive disorders (MDD) have been inconsistent, but often indicate greater morbidity following early OA. We considered factors associated with OA in 1033 carefully evaluated, systematically followed mood disorder subjects with DSM-5 BD (n = 505) or MDD (n = 528), comparing rates of descriptive and clinical characteristics following early (age <18), intermediate (18-40), or later onset (≥40 years), as well as regressing selected measures versus OA. Exposure time (years ill) was matched among these subgroups. As hypothesized, many features were associated with early OA: familial psychiatric illness, including BD, greater maternal age, early sexual abuse, nondepressive first episodes, co-occurring ADHD, suicide attempts and violent suicidal behavior, abuse of alcohol or drugs, smoking, and unemployment. Other features increased consistently with later OA: %-time-depressed (in BD and MDD, women and men), as well as depressions/year and intake ratings of depression, educational levels, co-occurring medical disorders, rates of marriage and number of children. OA averaged 7.5 years earlier in BD versus MDD (30.7 vs. 38.2). Some OA-associated measures may reflect maturation. Associations with family history and suicidal risk with earlier OA were expected; increases of time-depressed in both BD and MDD with later OA were not. We conclude that associations of OA with later morbidity are complex and not unidirectional but may be clinically useful.

Sections du résumé

BACKGROUND
Research findings on factors associated with onset-age (OA) with bipolar (BD) and major depressive disorders (MDD) have been inconsistent, but often indicate greater morbidity following early OA.
METHODS
We considered factors associated with OA in 1033 carefully evaluated, systematically followed mood disorder subjects with DSM-5 BD (n = 505) or MDD (n = 528), comparing rates of descriptive and clinical characteristics following early (age <18), intermediate (18-40), or later onset (≥40 years), as well as regressing selected measures versus OA. Exposure time (years ill) was matched among these subgroups.
RESULTS
As hypothesized, many features were associated with early OA: familial psychiatric illness, including BD, greater maternal age, early sexual abuse, nondepressive first episodes, co-occurring ADHD, suicide attempts and violent suicidal behavior, abuse of alcohol or drugs, smoking, and unemployment. Other features increased consistently with later OA: %-time-depressed (in BD and MDD, women and men), as well as depressions/year and intake ratings of depression, educational levels, co-occurring medical disorders, rates of marriage and number of children.
CONCLUSIONS
OA averaged 7.5 years earlier in BD versus MDD (30.7 vs. 38.2). Some OA-associated measures may reflect maturation. Associations with family history and suicidal risk with earlier OA were expected; increases of time-depressed in both BD and MDD with later OA were not. We conclude that associations of OA with later morbidity are complex and not unidirectional but may be clinically useful.

Identifiants

pubmed: 36059155
doi: 10.1111/acps.13497
pmc: PMC9826467
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-467

Informations de copyright

© 2022 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd.

Références

Arch Gen Psychiatry. 1973 May;28(5):656-8
pubmed: 4700678
Int J Geriatr Psychiatry. 2006 Jan;21(1):86-93
pubmed: 16323255
Braz J Psychiatry. 2016 Mar;38(1):6-10
pubmed: 26785105
J Affect Disord. 2004 Oct 1;82(1):21-7
pubmed: 15465573
J Pediatr. 2009 Jul;155(1):118-23
pubmed: 19394039
J Affect Disord. 2002 Apr;68(2-3):343-5
pubmed: 12063163
Chin Med J (Engl). 2015 Mar 20;128(6):811-5
pubmed: 25758278
Am J Psychiatry. 2006 Sep;163(9):1633-6
pubmed: 16946191
Am J Psychiatry. 1995 Mar;152(3):385-90
pubmed: 7864264
Bipolar Disord. 2005 Apr;7(2):111-8
pubmed: 15762851
Am J Geriatr Psychiatry. 2005 Oct;13(10):852-60
pubmed: 16223963
J Affect Disord. 2007 Jun;100(1-3):13-21
pubmed: 17223199
World Psychiatry. 2012 Feb;11(1):40-6
pubmed: 22295008
J Psychiatr Res. 2003 Jul-Aug;37(4):297-303
pubmed: 12765852
BMC Psychiatry. 2015 Feb 12;15:20
pubmed: 25775143
Clin Psychol Psychother. 2022 Jan;29(1):351-359
pubmed: 34128280
Bipolar Disord. 2016 Aug;18(5):389-403
pubmed: 27530107
Acta Psychiatr Scand. 2010 Jun;121(6):446-52
pubmed: 20040069
J Clin Psychiatry. 2013 Jul;74(7):723-31; quiz 731
pubmed: 23945450
J Affect Disord. 2015 Mar 15;174:83-8
pubmed: 25486276
Am J Psychiatry. 2003 May;160(5):999-1001
pubmed: 12727708
Arch Gen Psychiatry. 1988 Aug;45(8):742-7
pubmed: 3395203
J Psychiatr Res. 2021 Jul;139:150-158
pubmed: 34058654
J Clin Psychiatry. 2010 Jul;71(7):864-72
pubmed: 20667291
J Affect Disord. 2015 Jan 1;170:266-9
pubmed: 25265534
Bipolar Disord. 2003 Oct;5(5):340-8
pubmed: 14525554
J Affect Disord. 2008 Nov;111(1):52-60
pubmed: 18355924
J Affect Disord. 2015 Sep 15;184:1-12
pubmed: 26057335
J Affect Disord. 1988 Nov-Dec;15(3):255-68
pubmed: 2975298
J Nerv Ment Dis. 2004 Nov;192(11):796-9
pubmed: 15505527
J Affect Disord. 2017 Aug 1;217:218-224
pubmed: 28431382
Lancet Psychiatry. 2018 Jul;5(7):581-590
pubmed: 29887519
Acta Psychiatr Scand. 2022 Nov;146(5):456-467
pubmed: 36059155
Am J Psychiatry. 2000 Nov;157(11):1873-5
pubmed: 11058490
Eur Arch Psychiatry Clin Neurosci. 2008 Oct;258(7):385-93
pubmed: 18437277
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Arch Gen Psychiatry. 1990 May;47(5):465-73
pubmed: 2184797
J Affect Disord. 2015 Jul 1;179:1-5
pubmed: 25837715
J Affect Disord. 2013 Mar 20;146(1):34-8
pubmed: 23062746
J Affect Disord. 2008 Apr;107(1-3):77-88
pubmed: 17854907
Annu Rev Public Health. 2013;34:119-38
pubmed: 23514317
Transl Psychiatry. 2022 Mar 26;12(1):124
pubmed: 35347114
Arch Gen Psychiatry. 2008 May;65(5):513-20
pubmed: 18458203
Arch Gen Psychiatry. 1996 Apr;53(4):305-12
pubmed: 8634008
J Affect Disord. 2013 Sep 25;150(3):993-1000
pubmed: 23769605
Prim Care Companion J Clin Psychiatry. 2010;12(3):
pubmed: 20944770
J Affect Disord. 2000 Jun;58(3):215-21
pubmed: 10802130
Biol Psychiatry. 1999 Jul 15;46(2):202-11
pubmed: 10418695
J Affect Disord. 2012 May;138(3):259-67
pubmed: 22370067
J Clin Psychiatry. 2002 Nov;63(11):985-91
pubmed: 12444811
Psychiatry Res. 2011 Jan 30;185(1-2):27-32
pubmed: 20580841
Arch Gen Psychiatry. 2001 May;58(5):510-2
pubmed: 11343533
Acta Psychiatr Scand. 2016 Oct;134(4):281-6
pubmed: 26826334
BMJ Open. 2017 Aug 28;7(8):e015746
pubmed: 28851777
Eur Neuropsychopharmacol. 2022 Jul;60:55-75
pubmed: 35635997
Arch Gen Psychiatry. 1984 Jul;41(7):643-9
pubmed: 6732424
Biol Psychiatry. 2004 May 1;55(9):875-81
pubmed: 15110730
JAMA. 1996 Jul 24-31;276(4):293-9
pubmed: 8656541
Psychol Med. 2013 May;43(5):945-60
pubmed: 23228340
Bipolar Disord. 2013 May;15(3):306-13
pubmed: 23531096
Compr Psychiatry. 2020 May;99:152170
pubmed: 32146314
J Nerv Ment Dis. 2015 Aug;203(8):617-25
pubmed: 26186068
CNS Spectr. 2011 Jun;16(6):127-34
pubmed: 24725455
J Affect Disord. 2004 Aug;81(2):103-13
pubmed: 15306135
Neuropsychiatr Dis Treat. 2009;5:399-404
pubmed: 19649214
Mol Psychiatry. 2022 Jan;27(1):281-295
pubmed: 34079068
J Psychiatr Res. 2007 Apr-Jun;41(3-4):214-21
pubmed: 16690084
J Affect Disord. 2005 Mar;85(1-2):45-52
pubmed: 15780675
Am J Psychiatry. 2020 Jan 1;177(1):20-36
pubmed: 31537091
J Clin Psychiatry. 2012 Apr;73(4):e561-6
pubmed: 22579163
Parkinsonism Relat Disord. 2020 Oct;79:40-46
pubmed: 32862017
Biol Psychiatry. 2005 Jun 1;57(11):1467-73
pubmed: 15950022
Int J Geriatr Psychiatry. 2010 Dec;25(12):1266-71
pubmed: 20082348
Clin Pract Epidemiol Ment Health. 2011;7:140-7
pubmed: 21866230
J Affect Disord. 2015 Jun 1;178:71-8
pubmed: 25797049

Auteurs

Alessandro Miola (A)

International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts, USA.
Department of Psychiatry, University of Padova, Padua, Italy.

Leonardo Tondo (L)

International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts, USA.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Lucio Bini Mood Disorder Centers, Cagliari, Rome, Italy.

Paola Salvatore (P)

International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts, USA.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Center for Healthcare Organization & Implementation Research, US Veterans Administration Medical Center, Bedford, Massachusetts, USA.

Ross J Baldessarini (RJ)

International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts, USA.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH